logo logo-mobile

  • Home
  • About Us
    • Our Vision
    • Company Profile
    • Our History
    • Contact Us
  • Research
    • Intellectual Property
    • Scientific Publications
    • Awards & Recognition
  • Products & Service
    • Pipelines
    • Clinical Trials
    • Cooperation
  • Newsroom
    • Latest News
    • Media
English | 简体中文

logo logo-mobile

En | 中文
  • Home
  • About Us
    • Our Vision
    • Company Profile
    • Our History
    • Contact Us
  • Research
    • Intellectual Property
    • Scientific Publications
    • Awards & Recognition
  • Products & Service
    • Pipelines
    • Clinical Trials
    • Cooperation
  • Newsroom
    • Latest News
    • Media
English| 简体中文

Research

—

  • Home
  • Research
  • Scientific Publications

Intellectual Property

Scientific Publications

Awards & Recognition

  • Clinically approved combination immunotherapy: Current status, limitations, and future perspective
    Clinically approved combination immunotherapy: Current status, limitations, and future perspective
    2024-11-14
    启辰生
    Time:2024-11-14
    Lu L, Zhan M, Li XY, Zhang H, Dauphars DJ, Jiang J, Yin H, Li SY, Luo S, Li Y, He YW. Clinically approved combination immunotherapy: Current status, limitations, and future perspective. Curr Res Immun
    more
  • Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
    Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
    2024-11-13
    启辰生
    Time:2024-11-13
    Zhu P, Li SY, Ding J, Fei Z, Sun SN, Zheng ZH, Wei D, Jiang J, Miao JL, Li SZ, Luo X, Zhang K, Wang B, Zhang K, Pu S, Wang QT, Zhang XY, Wen GL, Liu JO, August JT, Bian H, Chen ZN, He YW. Combination
    more
  • Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
    Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
    2024-11-13
    启辰生
    Time:2024-11-13
    Lu, L., H. Zhang, M. Zhan, J. Jiang, H. Yin, D. J. Dauphars, S. Y. Li, Y. Li and Y. W. He (2020). "Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?" Sci
    more
  • Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.
    Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.
    2024-11-13
    启辰生
    Time:2024-11-13
    Lu, L., J. Jiang, M. Zhan, H. Zhang, Q. T. Wang, S. N. Sun, X. K. Guo, H. Yin, Y. Wei, S. Y. Li, J. O. Liu, Y. Li and Y. W. He (2021). "Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma
    more
  • Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
    Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
    2024-11-13
    启辰生
    Time:2024-11-13
    Lu, L., H. Zhang, M. Zhan, J. Jiang, H. Yin, D. J. Dauphars, S. Y. Li, Y. Li and Y. W. He (2020). "Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?" Front Cell De
    more
    • Prev
    • 1
    • 2

一 ABOUT US

  • Our Vision
  • Company Profile
  • Our History
  • Contact Us

一 Research

  • Intellectual Property
  • Scientific Publications
  • Awards & Recognition

一 Products & Service

  • Pipelines
  • Clinical Trials
  • Cooperation

一 Newsroom

  • Latest News
  • Media

一 Contact us

Contact us

WeChat Official Account

copyright 1993-2026Beijing Tricision Biotechnology CoLtd | NOJingCP2022016228